MAM
BHVN

Melqart Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Melqart Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-102,300
Closed -$14.9M – 79
2022
Q2 		$14.9M Buy
+102,300
New +$14.9M 1.15% 27